Liver Cancer Risk, Coffee, and Hepatitis C Virus Infection: a Nested Case-control Study in Japan
Overview
Authors
Affiliations
We examined hepatocellular carcinoma mortality in relation to coffee consumption and anti-hepatitis C virus (HCV) antibody seropositivity in a nested case-control study involving 96 cases. The multivariate-adjusted odds ratios (95% confidence interval) for daily coffee drinkers vs non-drinkers were 0.49 (0.25-0.96), 0.31 (0.11-0.85), and 0.75 (0.29-1.92) in all cases, in HCV-positive and in HCV-negative individuals, respectively.
Degertekin B, Tozun N, Soylemez A, Gurtay E, Bozkurt U, Yilmaz Y Hepatol Forum. 2022; 1(3):88-96.
PMID: 35949725 PMC: 9349493. DOI: 10.14744/hf.2020.2020.0026.
Inoue M, Tsugane S Curr Nutr Rep. 2019; 8(3):182-186.
PMID: 30977056 DOI: 10.1007/s13668-019-0274-1.
Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review.
Axley P, Ahmed Z, Ravi S, Singal A J Clin Transl Hepatol. 2018; 6(1):79-84.
PMID: 29607308 PMC: 5863002. DOI: 10.14218/JCTH.2017.00067.
Kennedy O, Roderick P, Buchanan R, Fallowfield J, Hayes P, Parkes J BMJ Open. 2017; 7(5):e013739.
PMID: 28490552 PMC: 5730000. DOI: 10.1136/bmjopen-2016-013739.
An updated dose-response meta-analysis of coffee consumption and liver cancer risk.
Yu C, Cao Q, Chen P, Yang S, Deng M, Wang Y Sci Rep. 2016; 6:37488.
PMID: 27910873 PMC: 5133591. DOI: 10.1038/srep37488.